FDA Drug recall D-0158-2016
TRI-MIX 10MCG+0.5MG+15MG/ML,5 mL vial, Rx only, Park Compounding Pharmacy 280 N. Westlake Blvd., Ste. 100 Westlake Village, CA 91362, (805)…
- FDA Drug
- Class II
- terminated
- Published 2015-11-04
On 2015-11-04 the FDA classified a Class II recall of TRI-MIX 10MCG+0.5MG+15MG/ML,5 mL vial, Rx only, Park Compounding Pharmacy 280 N. Westlake Blvd., Ste. 100 Westlake Village, CA 91362, (805)… by Chen Shwezin, citing lack of Assurance of Sterility: all sterile compounded products within expiry.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0158-2016 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2015-10-06 |
| Published | 2015-11-04 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Chen Shwezin |
| Distribution | CA |
Product
TRI-MIX 10MCG+0.5MG+15MG/ML,5 mL vial, Rx only, Park Compounding Pharmacy 280 N. Westlake Blvd., Ste. 100 Westlake Village, CA 91362, (805) 497-8258
Reason
Lack of Assurance of Sterility: all sterile compounded products within expiry
Identifiers
| code_info | Lot# 09152015@8, Exp, 10/15/15 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0158-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.